Everolimus Plus Lanreotide Shows Significant Benefits in New Standard in GEP-NET Treatment STARTER-NET with Slides Gastrointestinal Cancer Treatment 3 Mins Read Background: The treatment landscape for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been slow to evolve, with limited evidence supporting the…
